1 min read

ID: 765648

Short Link: https://gregory-ms.com/articles/765648/

Discovery Date: 25 July 2022, 11:30:10 UTC

Published Date: 2022-07-25 10:00:00

Source: PubMed

Link: https://pubmed.ncbi.nlm.nih.gov/35874814/?utm_source=Other&utm_medium=rss&utm_campaign=pubmed-2&utm_content=10guX6I3SqrbUeeLKSTD6FCRM44ewnrN2MKKTQLLPMHB4xNsZU&fc=20210216052009&ff=20220725073009&v=2.17.7

Manual Selection: true

Machine Learning Gaussian Naive Bayes Model: false

Abstract

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) were developed as insulinotropic and anti-hyperglycemic agents for the treatment of type 2 diabetes, but their neurotrophic and neuroprotective activities have been receiving increasing attention. Myelin plays a key role in the functional maintenance of the central and peripheral nervous systems, and recent in vivo and in vitro studies have shed light on the beneficial effects of GLP-1RAs on the formation and protection of myelin. In this…

Noun Phrases in Title

  • Glucagon-Like Peptide-1 Receptor Agonists
  • Potential Myelination-Inducible and Anti-Demyelinating Remedies
This is an independent project that runs on the good will of volunteers

You can help by spreading the word or by donating what you can to pay for the server costs.